Загрузка...
Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies
Pancreatic cancer is the fourth leading cause of cancer death in the US and is expected to become the second leading cause of cancer-related deaths in the next decade. Despite 5-fluorouracil/leucovorin with irinotecan and oxaliplatin (FOLFIRINOX) and gemcitabine/nab-paclitaxel significantly improvin...
Сохранить в:
| Опубликовано в: : | Drug Des Devel Ther |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4500614/ https://ncbi.nlm.nih.gov/pubmed/26185420 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S60328 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|